All PlansAdministrativeMedium impact
Voluntary nationwide recall: Potassium (Bluepoint – June)
UPMC Health Plan·Family Medicine, Internal Medicine, Cardiology +3 more·Pharmacy
Effective date
Jun 25, 2024
We identified it
Jun 20, 2026
Summary
BluePoint Laboratories is voluntarily recalling 21 batches of Potassium Chloride Extended-Release Capsules (750 mg) due to dissolution failure that could cause dangerous high potassium levels and cardiac arrest. Healthcare providers and patients should check if their medication is affected and consult before discontinuing use.
Action Required
Immediately: Clinical staff should identify patients prescribed Potassium Chloride Extended-Release Capsules 750 mg from BluePoint Laboratories and contact them to verify if their medication is from recalled batches. Direct patients to contact their pharmacy or visit FDA website to confirm recall status. Schedule consultation appointments before patients discontinue medication. Document all patient contacts and medication verifications in medical records.